At Metabolomic Technologies, we are committed to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs.
By tapping into the metabolomic fingerprint found in human biofluids, we are creating new tools for early detection and the management of disease.
Metabolomic Technologies is conducting novel research in metabolomics and machine learning, leading to the development of groundbreaking diagnostics.
We've validated technology in large multi-centre clinical trials.
Learn more about our clinical trials
Our work has been featured at various conferences, including the American College of Gastroenterology, in numerous publications and has been recognised by numerous awards, including the Frost & Sullivan Technology Innovation Leadership Award.